ArticleScientific data2026
An integrated single-cell transcriptomic and microbiome dataset of orbital adipose tissue in thyroid eye disease.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Thyroid eye disease (TED), also historically referred to as thyroid-associated ophthalmopathy (TAO) or Graves' orbitopathy (GO), is an autoimmune ophthalmopathy characterized by inflammation and adipogenesis within orbital adipose (OA) tissue. While the contribution of immune cell infiltration and fibroblast activation is recognized, the cellular heterogeneity and the potential role of local microbial dysbiosis in the orbital microenvironment remain poorly defined. Here, we present a multi-omics dataset derived from OA of patients with TED and healthy controls collected at Beijing Tongren Hospital. The dataset comprises single-cell RNA sequencing (scRNA-seq) data generated from human orbital adipose tissue and subcutaneous fat. Following quality control filtering and doublet removal, a total of 61,302 high-quality singlet cells were retained for downstream analyses, capturing the transcriptomic landscape of orbital fibroblasts, immune subsets, and vascular cells. In parallel, 16S rRNA gene sequencing was performed on orbital adipose tissue samples collected from the integrated study cohort, alongside environmental samples for contamination assessment, to characterize the low-biomass orbital microbiome DNA signatures. Raw sequencing reads, quality-controlled gene-expression matrices, and contamination-corrected microbial feature tables are provided. Our dataset provides an opportunity to investigate the crosstalk between host cellular immunity and potential local microbiome signatures, facilitating hypothesis generation regarding host-microbiome crosstalk and the exploration of novel therapeutic targets for TED.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.